Ernst Lengyel

Ernst Lengyel

Department of Obstetrics and Gynecology, University of Chicago

Affiliated withUniversity of Chicago

Research Area

Biography

Ernst Lengyel has not added Biography.
If you are Ernst Lengyel and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
Publication title

Cited by 20

2015

Other Publications

Article
Year
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion.

Cancer research| PubMed ID: 17308108

2007
2006
2002
2003
2004
C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu.

International journal of cancer. Journal international du cancer| PubMed ID: 15455388

2005
2004
2004
2005
Tyrosine kinase mutations in human cancer.

Current molecular medicine| PubMed ID: 17311534

2007
2007
2007
Let-7 expression defines two differentiation stages of cancer.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 17600087

2007
2007
2008
2008
2008
2008
A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings.

Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry| PubMed ID: 18815565

2009
2008
2008
MMP-2 functions as an early response protein in ovarian cancer metastasis.

Cell cycle (Georgetown, Tex.)| PubMed ID: 19221481

2009
2009
2009
2010
2009
2009
2009
2010
2010
CD95 promotes tumour growth.

Nature| PubMed ID: 20505730

2010
Ovarian cancer development and metastasis.

The American journal of pathology| PubMed ID: 20651229

2010
Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 21149615

2011
2011
2011
2011
Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 21551255

2011
Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1.

International journal of cancer. Journal international du cancer| PubMed ID: 21618519

2012
FOXL2 and SOX9 distinguish the lineage of the sex cord-stromal cells in gonadoblastomas.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society| PubMed ID: 21682576

2011
2011
2012
2011
2011
2012
2012
HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts.

The Journal of clinical investigation| PubMed ID: 22945634

2012
2012
2013
2013
Adipose tissue and adipocytes support tumorigenesis and metastasis.

Biochimica et biophysica acta| PubMed ID: 23500888

2013
2013
2013
2014
Three-dimensional modeling of ovarian cancer.

Advanced drug delivery reviews| PubMed ID: 25034878

2014
2014
2014
Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models.

American journal of obstetrics and gynecology| PubMed ID: 25446664

2015
2014
2015
Molecular pathways: trafficking of metabolic resources in the tumor microenvironment.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 25691772

2015
2015
2015
2015
2015
2015
2015
2015